CytoDyn Inc.Company Review & Valuation

CYDY
OTC Markets
Latest Price
5.20USD
Market Capitalization
2,702.43mUSD

About CytoDyn Inc.

CytoDyn Inc., a clinical-stage biotechnology company, focuses on the clinical development and commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus (HIV) infection. Its lead product is PRO 140, a therapeutic anti-viral agent, which is iShow more n Phase IIb treatment substitution trial, Phase IIb extension study, Phase IIb/III pivotal trial, and Phase IIb/III investigative trial for HIV; and Phase II trial for graft-versus-host disease. The company is based in Vancouver, Washington. Show less

Industry
Biotechnology
HQ Location
Vancouver, Washington

Stock Price

Price data not available for CytoDyn Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

back to top